These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25536721

  • 1. Cystatin C as biomarker of contrast-induced nephropathy in pediatric cardiac angiography.
    Osman Ö, Ayee Deniz O, Abdülkadir E, Cihat Ş, Hüsnü Oğuz S, Avse Banu Ç.
    Turk J Med Sci; 2014; 44(2):178-85. PubMed ID: 25536721
    [Abstract] [Full Text] [Related]

  • 2. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

  • 3. NGAL is an early predictive biomarker of contrast-induced nephropathy in children.
    Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P.
    Pediatr Nephrol; 2007 Dec; 22(12):2089-95. PubMed ID: 17874137
    [Abstract] [Full Text] [Related]

  • 4. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L, Pu X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [Abstract] [Full Text] [Related]

  • 5. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.
    Shaker OG, El-Shehaby A, El-Khatib M.
    Angiology; 2010 Nov; 61(8):731-6. PubMed ID: 20529972
    [Abstract] [Full Text] [Related]

  • 6. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.
    Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q.
    Nephron Clin Pract; 2008 Nov; 108(3):c176-81. PubMed ID: 18287807
    [Abstract] [Full Text] [Related]

  • 7. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 Mar; 65(3):216-23. PubMed ID: 23378196
    [Abstract] [Full Text] [Related]

  • 8. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
    Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S.
    Kidney Blood Press Res; 2007 Mar; 30(6):408-15. PubMed ID: 17901710
    [Abstract] [Full Text] [Related]

  • 9. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery.
    Seitz S, Rauh M, Gloeckler M, Cesnjevar R, Dittrich S, Koch AM.
    Swiss Med Wkly; 2013 Mar; 143():w13744. PubMed ID: 23348800
    [Abstract] [Full Text] [Related]

  • 10. Cystatin C, but not urinary or serum NGAL, may be associated with contrast induced nephropathy after percutaneous coronary invasive procedures: A single center experience on a limited number of patients.
    Cecchi E, Avveduto G, D'Alfonso MG, Terreni A, Gelera E, Caldini A, Giglioli C.
    Acta Med Acad; 2017 May; 46(1):34-43. PubMed ID: 28605926
    [Abstract] [Full Text] [Related]

  • 11. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S, Zheng Z, Tang X, Peng L, Luo Y, Dong R, Zhao Y, Liu J.
    J Comput Assist Tomogr; 2015 May; 39(6):969-74. PubMed ID: 26248154
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
    Kafkas N, Liakos C, Zoubouloglou F, Dagadaki O, Dragasis S, Makris K.
    Clin Cardiol; 2016 Aug; 39(8):464-70. PubMed ID: 27175937
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN).
    Liao B, Nian W, Xi A, Zheng M.
    Med Sci Monit; 2019 Jan 19; 25():565-570. PubMed ID: 30659575
    [Abstract] [Full Text] [Related]

  • 14. Serum Cystatin C as an Early Marker of Neutrophil Gelatinase-associated Lipocalin-positive Acute Kidney Injury Resulting from Cardiopulmonary Bypass in Infants with Congenital Heart Disease.
    Herbert C, Patel M, Nugent A, Dimas VV, Guleserian KJ, Quigley R, Modem V.
    Congenit Heart Dis; 2015 Jan 19; 10(4):E180-8. PubMed ID: 25727405
    [Abstract] [Full Text] [Related]

  • 15. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Padhy M, Kaushik S, Girish MP, Mohapatra S, Shah S, Koner BC.
    Clin Chim Acta; 2014 Aug 05; 435():48-52. PubMed ID: 24804935
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C.
    Am J Cardiol; 2015 Jul 01; 116(1):104-11. PubMed ID: 25943992
    [Abstract] [Full Text] [Related]

  • 17. Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery.
    Ghonemy TA, Amro GM.
    Saudi J Kidney Dis Transpl; 2014 May 01; 25(3):582-8. PubMed ID: 24821156
    [Abstract] [Full Text] [Related]

  • 18. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
    Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S.
    Nephrology (Carlton); 2016 Apr 01; 21(4):295-300. PubMed ID: 26370061
    [Abstract] [Full Text] [Related]

  • 19. Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses.
    Mahapatro A, Nobakht S, Mukesh S, Daryagasht AA, Korsapati AR, Jain SM, Soltani Moghadam S, Moosavi R, Javid M, Hassanipour S, Prabhu SV, Keivanlou MH, Amini-Salehi E, Nayak SS.
    Eur J Med Res; 2024 Apr 01; 29(1):210. PubMed ID: 38561791
    [Abstract] [Full Text] [Related]

  • 20. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.
    Benzer M, Alpay H, Baykan Ö, Erdem A, Demir IH.
    Ren Fail; 2016 Apr 01; 38(1):27-34. PubMed ID: 26584598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.